review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.MIB.2010.05.009 |
P8608 | Fatcat ID | release_bcj7p4yh6vatbazskyssi2rp6a |
P932 | PMC publication ID | 2920345 |
P698 | PubMed publication ID | 20538505 |
P5875 | ResearchGate publication ID | 44663992 |
P50 | author | Adolfo García-Sastre | Q4684232 |
Gijs A Versteeg | Q54438384 | ||
P2860 | cites work | Z proteins of New World arenaviruses bind RIG-I and interfere with type I interferon induction | Q22001518 |
Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity | Q24296473 | ||
Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus | Q24311228 | ||
Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I | Q24312113 | ||
RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate | Q24315639 | ||
RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway | Q24317317 | ||
DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response | Q24317784 | ||
Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I | Q24336258 | ||
The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter | Q24558779 | ||
Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway | Q24563231 | ||
GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS | Q24675888 | ||
Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist | Q27472136 | ||
Blocking of Interferon-Induced Jak-Stat Signaling by Japanese Encephalitis Virus NS5 through a Protein Tyrosine Phosphatase-Mediated Mechanism | Q27473235 | ||
La Crosse Bunyavirus Nonstructural Protein NSs Serves To Suppress the Type I Interferon System of Mammalian Hosts | Q27480353 | ||
Ubiquitination and proteasomal degradation of interferon regulatory factor-3 induced by Npro from a cytopathic bovine viral diarrhea virus | Q27481222 | ||
Interferon-inducible antiviral effectors | Q27486790 | ||
Identification and Biochemical Characterization of Small-Molecule Inhibitors of West Nile Virus Serine Protease by a High-Throughput Screen | Q27486814 | ||
Identification of Hepatitis C Virus NS5A Inhibitors | Q27490539 | ||
The NS5 Protein of the Virulent West Nile Virus NY99 Strain Is a Potent Antagonist of Type I Interferon-Mediated JAK-STAT Signaling | Q27491054 | ||
Mutations Abrogating VP35 Interaction with Double-Stranded RNA Render Ebola Virus Avirulent in Guinea Pigs | Q27658947 | ||
Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3 | Q27861127 | ||
The cellular inhibitor of the PKR protein kinase, P58(IPK), is an influenza virus-activated co-chaperone that modulates heat shock protein 70 activity | Q28295453 | ||
A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice | Q28609778 | ||
Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures | Q29615028 | ||
Recognition of cytosolic DNA activates an IRF3-dependent innate immune response | Q29616156 | ||
The AIM2 inflammasome is critical for innate immunity to Francisella tularensis | Q29622833 | ||
Novel influenza virus NS1 antagonists block replication and restore innate immune function | Q30439074 | ||
Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines | Q33294059 | ||
Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression | Q33383235 | ||
Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation | Q33406230 | ||
Chemical library screens targeting an HIV-1 accessory factor/host cell kinase complex identify novel antiretroviral compounds | Q33508889 | ||
Mumps virus V protein antagonizes interferon without the complete degradation of STAT1. | Q33707477 | ||
Cytopathogenesis and inhibition of host gene expression by RNA viruses | Q34010277 | ||
Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication | Q34717075 | ||
Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach | Q34820655 | ||
Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus | Q34999702 | ||
Cleavage of IPS-1 in cells infected with human rhinovirus. | Q35001899 | ||
Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation. | Q35002940 | ||
Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation | Q35036515 | ||
Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR. | Q35107614 | ||
The cellular protein P58IPK regulates influenza virus mRNA translation and replication through a PKR-mediated mechanism | Q35784635 | ||
The molecular chaperone hsp40 regulates the activity of P58IPK, the cellular inhibitor of PKR. | Q35900773 | ||
The herpes simplex virus ICP27 protein: a multifunctional post-transcriptional regulator of gene expression | Q36139348 | ||
Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection | Q36315811 | ||
Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus | Q36484103 | ||
Random mutagenesis defines a domain of Theiler's virus leader protein that is essential for antagonism of nucleocytoplasmic trafficking and cytokine gene expression | Q37410858 | ||
A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein | Q37442279 | ||
Mucosal vaccines: novel advances in technology and delivery | Q37559647 | ||
Recognition of viruses by cytoplasmic sensors | Q37671348 | ||
NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase | Q39195523 | ||
Classical swine fever virus Erns glycoprotein antagonizes induction of interferon-beta by double-stranded RNA. | Q39797106 | ||
Zinc binding in pestivirus N(pro) is required for interferon regulatory factor 3 interaction and degradation. | Q39835627 | ||
Respiratory syncytial virus proteins modulate suppressors of cytokine signaling 1 and 3 and the type I interferon response to infection by a toll-like receptor pathway | Q39852751 | ||
A Japanese encephalitis virus vaccine candidate strain is attenuated by decreasing its interferon antagonistic ability | Q39861100 | ||
Development of a live-attenuated influenza B DeltaNS1 intranasal vaccine candidate. | Q39861118 | ||
Protein kinase R reveals an evolutionary model for defeating viral mimicry | Q39910707 | ||
RNase-dependent inhibition of extracellular, but not intracellular, dsRNA-induced interferon synthesis by Erns of pestiviruses. | Q39939094 | ||
Hepatitis A virus protein 2B suppresses beta interferon (IFN) gene transcription by interfering with IFN regulatory factor 3 activation | Q39971611 | ||
Cutting edge: innate immune response triggered by influenza A virus is negatively regulated by SOCS1 and SOCS3 through a RIG-I/IFNAR1-dependent pathway. | Q40016479 | ||
Tick-borne encephalitis virus NS5 associates with membrane protein scribble and impairs interferon-stimulated JAK-STAT signalling | Q40044008 | ||
Measles virus V protein blocks Jak1-mediated phosphorylation of STAT1 to escape IFN-alpha/beta signaling | Q40096640 | ||
A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis | Q40167332 | ||
Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists | Q40208162 | ||
Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. | Q40319046 | ||
Glycosylation of classical swine fever virus E(rns) is essential for binding double-stranded RNA and preventing interferon-beta induction | Q40378906 | ||
Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses | Q40491428 | ||
A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus | Q40508331 | ||
IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. | Q40674809 | ||
Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus | Q41847342 | ||
Differential inhibition of type I interferon induction by arenavirus nucleoproteins | Q41937252 | ||
Measles virus circumvents the host interferon response by different actions of the C and V proteins. | Q42249885 | ||
Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane | Q42624738 | ||
Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase | Q44539835 | ||
P58(IPK), a plant ortholog of double-stranded RNA-dependent protein kinase PKR inhibitor, functions in viral pathogenesis. | Q52105752 | ||
The mengovirus leader protein blocks interferon-α/β gene transcription and inhibits activation of interferon regulatory factor 3 | Q57206555 | ||
Proteolytic Cleavage of the p65-RelA Subunit of NF-κB during Poliovirus Infection | Q58664420 | ||
P433 | issue | 4 | |
P304 | page(s) | 508-516 | |
P577 | publication date | 2010-06-10 | |
P1433 | published in | Current Opinion in Microbiology | Q15752444 |
P1476 | title | Viral tricks to grid-lock the type I interferon system | |
P478 | volume | 13 |
Q36005999 | A RIG-I 2CARD-MAVS200 Chimeric Protein Reconstitutes IFN-β Induction and Antiviral Response in Models Deficient in Type I IFN Response. |
Q30423962 | A Sendai virus-derived RNA agonist of RIG-I as a virus vaccine adjuvant. |
Q60300348 | A virus-encoded type I interferon decoy receptor enables evasion of host immunity through cell-surface binding |
Q37123453 | Alphacoronavirus protein 7 modulates host innate immune response |
Q38218817 | An evolving arsenal: viral RNA detection by RIG-I-like receptors |
Q39347222 | Antagonism of type I interferon by flaviviruses |
Q62383594 | Antiviral Agents Against Ebola Virus Infection: Repositioning Old Drugs and Finding Novel Small Molecules |
Q64902925 | Antiviral RNAi in Insects and Mammals: Parallels and Differences. |
Q42212383 | Antiviral activity of human OASL protein is mediated by enhancing signaling of the RIG-I RNA sensor |
Q36076825 | Biochemical and Structural Insights into the Preference of Nairoviral DeISGylases for Interferon-Stimulated Gene Product 15 Originating from Certain Species |
Q37258717 | Biology of the TAM receptors |
Q40239941 | Can the mild clinical course of crimean-congo hemorrhagic fever in children be explained by cytokine responses? |
Q28534367 | Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing |
Q33945559 | Characterization of Aedes aegypti innate-immune pathways that limit Chikungunya virus replication |
Q37559660 | Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses |
Q59354151 | Constitutively Active MDA5 Proteins Are Inhibited by Paramyxovirus V Proteins |
Q38776765 | Constrained evolvability of interferon suppression in an RNA virus |
Q58811125 | Could inhibiting IL-8 enhance HBV IFN-α treatment? |
Q35082211 | DAMP molecule S100A9 acts as a molecular pattern to enhance inflammation during influenza A virus infection: role of DDX21-TRIF-TLR4-MyD88 pathway |
Q42415433 | DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. |
Q26824882 | Defective viral genomes: critical danger signals of viral infections |
Q34395385 | Dengue virus serotype 2 blocks extracellular signal-regulated kinase and nuclear factor-κB activation to downregulate cytokine production |
Q41944558 | Different STAT Transcription Complexes Drive Early and Delayed Responses to Type I IFNs |
Q39070794 | Different functions of the common P/V/W and V-specific domains of rinderpest virus V protein in blocking IFN signalling |
Q40213813 | Discrimination of Self and Non-Self Ribonucleic Acids |
Q38070990 | Disease mechanisms in rheumatology--tools and pathways: plasmacytoid dendritic cells and their role in autoimmune rheumatic diseases |
Q33420049 | Disruption of type I interferon signaling by the nonstructural protein of severe fever with thrombocytopenia syndrome virus via the hijacking of STAT2 and STAT1 into inclusion bodies |
Q27675985 | Diversity of Ubiquitin and ISG15 Specificity among Nairoviruses' Viral Ovarian Tumor Domain Proteases |
Q34262097 | Dual modulation of type I interferon response by bluetongue virus |
Q38419101 | Early IFN type I response: Learning from microbial evasion strategies |
Q56377156 | Effects of type I interferons in malaria |
Q33927772 | Enterovirus71 (EV71) utilise host microRNAs to mediate host immune system enhancing survival during infection |
Q51148937 | Exogenous Stimulation of Type I Interferon Protects Mice with Chronic Granulomatous Disease from Aspergillosis through Early Recruitment of Host-Protective Neutrophils into the Lung. |
Q40520906 | Experimental evolution of an RNA virus in cells with innate immunity defects. |
Q37628236 | Feline Panleucopenia Virus NS2 Suppresses the Host IFN-β Induction by Disrupting the Interaction between TBK1 and STING. |
Q35758591 | Fluorescence-Activated Cell Sorting-Based Analysis Reveals an Asymmetric Induction of Interferon-Stimulated Genes in Response to Seasonal Influenza A Virus |
Q35003207 | Glycosaminoglycans mediate retention of the poxvirus type I interferon binding protein at the cell surface to locally block interferon antiviral responses |
Q54940015 | Homodimerisation-independent cleavage of dsRNA by a pestiviral nicking endoribonuclease. |
Q21558779 | IFITM proteins restrict viral membrane hemifusion |
Q35913195 | IFN-β-inducing, unusual viral RNA species produced by paramyxovirus infection accumulated into distinct cytoplasmic structures in an RNA-type-dependent manner |
Q39172917 | IFNβ/TNFα synergism induces a non-canonical STAT2/IRF9-dependent pathway triggering a novel DUOX2 NADPH oxidase-mediated airway antiviral response. |
Q38060973 | Identification and utility of innate immune system evasion mechanisms of ASFV. |
Q39241501 | Identification of amino acid residues important for anti-IFN activity of porcine reproductive and respiratory syndrome virus non-structural protein 1. |
Q36708682 | Identification of critical amino acids within the nucleoprotein of Tacaribe virus important for anti-interferon activity. |
Q34712064 | Identification of residues of SARS-CoV nsp1 that differentially affect inhibition of gene expression and antiviral signaling |
Q34473943 | Identification of small molecules with type I interferon inducing properties by high-throughput screening |
Q30238887 | Immunobiology of Ebola and Lassa virus infections |
Q35763742 | Immunostimulatory Defective Viral Genomes from Respiratory Syncytial Virus Promote a Strong Innate Antiviral Response during Infection in Mice and Humans. |
Q42953374 | Immunosuppression by hemorrhagic fever-causing viruses |
Q38244748 | InTRIMsic immunity: Positive and negative regulation of immune signaling by tripartite motif proteins |
Q28395006 | Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development |
Q34405097 | Influenza A virus does not encode a tetherin antagonist with Vpu-like activity and induces IFN-dependent tetherin expression in infected cells |
Q28079141 | Inhibition of Innate Immune Responses Is Key to Pathogenesis by Arenaviruses |
Q35744520 | Inhibition of pyrimidine synthesis reverses viral virulence factor-mediated block of mRNA nuclear export |
Q28950689 | Inhibition of type I interferon induction and signalling by mosquito-borne flaviviruses |
Q37394607 | Innate immune response to arenaviral infection: a focus on the highly pathogenic New World hemorrhagic arenaviruses. |
Q41919279 | Integrated modeling and analysis of intracellular and intercellular mechanisms in shaping the interferon response to viral infection |
Q35814729 | Integrative Genomics-Based Discovery of Novel Regulators of the Innate Antiviral Response |
Q28585561 | Interferon-induced tetherin restricts vesicular stomatitis virus release in neurons |
Q28482256 | Intraspecies variation in the emergence of hyperinfectious bacterial strains in nature |
Q34282240 | Junín virus infection activates the type I interferon pathway in a RIG-I-dependent manner |
Q92757352 | Lyssavirus matrix protein cooperates with phosphoprotein to modulate the Jak-Stat pathway |
Q47548908 | MERS-CoV 4b protein interferes with the NF-κB-dependent innate immune response during infection. |
Q29451356 | Maternal-Fetal Transmission of Zika Virus: Routes and Signals for Infection |
Q39445395 | Measles virus C protein interferes with Beta interferon transcription in the nucleus. |
Q30588275 | Metagenomic analysis of double-stranded DNA viruses in healthy adults |
Q42542221 | Modular cell-based platform for high throughput identification of compounds that inhibit a viral interferon antagonist of choice |
Q34645914 | Molecular mechanism of arenavirus assembly and budding |
Q35751132 | Monitoring activation of the antiviral pattern recognition receptors RIG-I and PKR by limited protease digestion and native PAGE. |
Q41831354 | Mouse gammaherpesvirus-68 infection acts as a rheostat to set the level of type I interferon signaling in primary macrophages |
Q30516536 | Multi-layered stochasticity and paracrine signal propagation shape the type-I interferon response |
Q38145679 | Non-encapsidation activities of the capsid proteins of positive-strand RNA viruses |
Q55357132 | Nonstructural proteins nsp2TF and nsp2N of porcine reproductive and respiratory syndrome virus (PRRSV) play important roles in suppressing host innate immune responses. |
Q37990940 | Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions |
Q38207011 | Oncolytic viruses and their application to cancer immunotherapy |
Q66678833 | Principles of Effective and Robust Innate Immune Response to Viral Infections: A Multiplex Network Analysis |
Q38364656 | RNA degradation in antiviral immunity and autoimmunity |
Q38712840 | RNA-Seq Based Transcriptome Analysis of the Type I Interferon Host Response upon Vaccinia Virus Infection of Mouse Cells |
Q36561303 | Regulation of TLR3 Activation by S100A9. |
Q30413201 | Regulatory, biosafety and safety challenges for novel cells as substrates for human vaccines |
Q34524628 | RelAp43, a member of the NF-κB family involved in innate immune response against Lyssavirus infection |
Q38736159 | Residues K465 and G467 within the Cytoplasmic Domain of GP2 Play a Critical Role in the Persistence of Lymphocytic Choriomeningitis Virus in Mice |
Q39852751 | Respiratory syncytial virus proteins modulate suppressors of cytokine signaling 1 and 3 and the type I interferon response to infection by a toll-like receptor pathway |
Q37547591 | Rotavirus NSP1 protein inhibits interferon-mediated STAT1 activation |
Q42558105 | STAT2-directed pathogen responses. |
Q35361219 | Sensing of immature particles produced by dengue virus infected cells induces an antiviral response by plasmacytoid dendritic cells |
Q35008803 | Sequestration by IFIT1 impairs translation of 2'O-unmethylated capped RNA. |
Q36343260 | Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity |
Q41491260 | Single-cell analysis shows that paracrine signaling by first responder cells shapes the interferon-β response to viral infection. |
Q38784939 | Spring Viremia of Carp Virus N Protein Suppresses Fish IFNφ1 Production by Targeting the Mitochondrial Antiviral Signaling Protein |
Q38152910 | Strategies of highly pathogenic RNA viruses to block dsRNA detection by RIG-I-like receptors: hide, mask, hit. |
Q40229759 | Structural Insights into the Interaction of Coronavirus Papain-Like Proteases and Interferon-Stimulated Gene Product 15 from Different Species. |
Q37560797 | Subcellular Localizations of RIG-I, TRIM25, and MAVS Complexes |
Q38798967 | Suppression of Type I Interferon Production by Human T-Cell Leukemia Virus Type 1 Oncoprotein Tax through Inhibition of IRF3 Phosphorylation. |
Q35186341 | Systemic responses during local viral infections: type I IFNs sound the alarm |
Q52727275 | Tacrolimus interacts with voriconazole to reduce the severity of fungal keratitis by suppressing IFN-related inflammatory responses and concomitant FK506 and voriconazole treatment suppresses fungal keratitis. |
Q38109390 | Targeting the viral Achilles' heel: recognition of 5'-triphosphate RNA in innate anti-viral defence |
Q40086149 | Ten Strategies of Interferon Evasion by Viruses |
Q37827428 | Tetherin and its viral antagonists |
Q56353961 | The A-Z of Zika drug discovery |
Q60950437 | The Amino-Terminal Region of Hepatitis E Virus ORF1 Containing a Methyltransferase (Met) and a Papain-Like Cysteine Protease (PCP) Domain Counteracts Type I Interferon Response |
Q35299892 | The Ebolavirus VP24 protein blocks phosphorylation of p38 mitogen-activated protein kinase |
Q40072930 | The K186E Amino Acid Substitution in the Canine Influenza Virus H3N8 NS1 Protein Restores Its Ability To Inhibit Host Gene Expression. |
Q27680413 | The Structure of Classical Swine Fever Virus Npro: A Novel Cysteine Autoprotease and Zinc-Binding Protein Involved in Subversion of Type I Interferon Induction |
Q34388476 | The human adenovirus type 5 E1B 55 kDa protein obstructs inhibition of viral replication by type I interferon in normal human cells |
Q37157195 | The importance of immune evasion in the pathogenesis of rabies virus. |
Q27924714 | The many faces of the flavivirus NS5 protein in antagonism of type I interferon signaling |
Q28481008 | The nitric oxide pathway provides innate antiviral protection in conjunction with the type I interferon pathway in fibroblasts |
Q36978628 | The rabies virus interferon antagonist P protein interacts with activated STAT3 and inhibits Gp130 receptor signaling |
Q37395985 | The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus |
Q39150549 | Toscana virus inhibits the interferon beta response in cell cultures |
Q35141456 | Transcriptional approach to study porcine tracheal epithelial cells individually or dually infected with swine influenza virus and Streptococcus suis |
Q35594559 | Type I interferon response is delayed in human astrovirus infections |
Q28255842 | Type I interferons in infectious disease |
Q39317949 | Ubiquitin enzymes in the regulation of immune responses |
Q42049627 | Uncoupling of the dynamics of host-pathogen interaction uncovers new mechanisms of viral interferon antagonism at the single-cell level |
Q38121280 | Viral evasion mechanisms of early antiviral responses involving regulation of ubiquitin pathways |
Q42144884 | Visualizing the beta interferon response in mice during infection with influenza A viruses expressing or lacking nonstructural protein 1. |
Q55385020 | ZIKV Infection Induces an Inflammatory Response but Fails to Activate Types I, II, and III IFN Response in Human PBMC. |
Q24261402 | Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling |
Q32183208 | Zika Virus: Recent Advances towards the Development of Vaccines and Therapeutics |
Q47215672 | Zika virus infection induces host inflammatory responses by facilitating NLRP3 inflammasome assembly and interleukin-1β secretion |
Q67200928 | m6A modification controls the innate immune response to infection by targeting type I interferons |
Search more.